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The acute anti-lipolytic effect of human growth hormone (hGH) in maximally noradrenaline-stimulated in- 
tact rat adipocytes was selectively associated with increased phosphorylation of a 46 kDa plasma membrane 
protein which was highly enriched by hGH-Sepharose chromatography. The same protein was also phos- 
phorylated by an endogenous protein kinase in isolated plasma membranes, although then no hGH effect 
could be demonstrated. About 14% of the phosphate incorporated into the protein in isolated plasma mem- 
branes was found in tyrosine residues and the remainder in serine and threonine. The possible relation of 
the 46 kDa protein with the hGH plasma membrane receptor is discussed. 
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1. INTRODUCTION 
hGH possesses diabetogenic and, when given to 
hypophysectomised animals, insulin-like proper- 
ties [1,2]. We have recently shown that in in vitro 
the acute anti-lipolytic (insulin-like) effect of hGH 
(which may also be seen with adipocytes from nor- 
mal rats when no hGH has been present in the 
medium during the first 3 h after isolation) on 
maximally noradrenaline-stimulated isolated rat 
adipocytes is the result of a decreased 
phosphorylation of the hormone-sensitive lipase, 
as with insulin [3]. In the case of insulin, one 
generally held view is that the signal chain is in- 
itiated by the phosphorylation and thereby the ac- 
tivation of the insulin receptor P-subunit tyrosine 
kinase, with subsequent amplification of the signal 
through a cascade of intracellular protein 
phosphorylations and/or dephosphorylations. In 
Abbreviations: BSA, bovine serum albumin; hGH, 
human growth hormone; PAGE, polyacrylamide gel 
electrophoresis; PMSF, phenylmethanesulfonyl fluoride 
view of the observed similarity between the 
mechanisms for the anti-lipolytic effect caused by 
the two hormones, we have speculated on the ex- 
istence of a common intracellular signal -chain 
starting from distinct plasma membrane receptors 
[4]. As a starting point to approach experimentally 
this question, we have examined the phosphoryla- 
tion of adipocyte plasma membrane protein(s) 
associated with the anti-lipolytic effect of hGH. 
2. MATERIALS AND METHODS 
BSA. fraction V (Sigma) was dialysed and defat- 
ted before use [5]. Hepes was bought from 
Schwartz-Mann. All concentrations are final con- 
centrations. Fat cells were isolated from 
epididymal fat pads of 120- 150 g Sprague-Dawley 
rats, age 31-36 days with collagenase (Wor- 
thington) in Hepes buffer [6]. After 2 h the cells 
were suspended at a final concentration of 5% 
(v/v) in fresh Krebs-Ringer buffer without 
phosphate. The metabolic integrity of the cells was 
ascertained regularly [7]. 
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26 ml of the cell suspension containing 5 mCi of 
[32P]orthophosphate (Amersham, final concentra- 
tion 50 PM) were preincubated for 50 min at pH 
7.40 and 37°C in each of two pH-stat titrator vials. 
After 50 min, L-noradrenaline bitartrate (Sigma, 
final concentration 100 nM) was added to both 
samples and the fatty acid release measured by pH- 
stat titration [8]. At the peak of the fatty acid 
release (see fig.1) hGH (Crescormon, KabiVitrum, 
Sweden), 700 nM, was added to one of the 
samples. When the inhibition of the noradrenaline- 
induced lipolysis by hGH was maximal, the cells of 
both suspensions were quickly washed by cen- 
trifugation three times in ice-cold 20 mM Tris- 
HCl, pH 7.4, and 255 mM sucrose containing 
1 mM ATP, 50 mM NaF, 1 mM EDTA and 
10 pg/ml each of leupeptin, pepstatin and antipain 
(Peptide Institute). All the subsequent steps were 
carried out at 4°C. 
The cells were homogenised in a Potter- 
Elvehjelm tissue grinder and the homogenates were 
then fractionated [9] to produce a plasma mem- 
brane fraction, a high density and a Golgi-enriched 
low density microsomal fraction. The remaining 
400000 x g,,, supernatant was designated the 
cytosolic fraction. The plasma membrane fraction 
was obtained from a Percoll gradient [9] by 
suspension of the initial 16000 x gmaX pellet after 
it had been washed in homogenisation medium and 
pelleted once more at 16000 x g,,,. After the Per- 
co11 had been removed [9], the plasma membrane 
fractions were solubilised in 3.9 ml of 50 mM Tris- 
HCl, pH 7.4, 10 mM MgClz, 255 mM sucrose and 
1% Triton X-100 by vigorous shaking for 1 h. The 
small remnant of insoluble matter was removed by 
centrifugation at 150000 x gmax for another hour. 
The solubilised plasma membrane proteins were 
fractionated by affinity chromatography on hGH 
immobilised to CNBr-activated Sepharose 4B 
(Pharmacia), 1 ml bead volume, equilibrated with 
50 mM Tris-HCl, pH 7.4, 10 mM MgClz, 255 mM 
sucrose and 0.1% Triton X-100 (column buffer). 
After the protein solutions had been added to the 
column it was washed with 4 ml of the column buf- 
fer. Finally, the column was eluted with column 
buffer made 3 M with respect o KI and 4 ml of the 
effluent was collected. 
Both the ‘column washings’ and the 3 M KI 
eluates were concentrated to 0.1 ml using 
microconcentrators (Centricon 10, Amicon). 
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Finally, the samples were precipitated and mem- 
brane lipids and the Triton X-100 were extracted 
[lo] and the samples subjected to SDS-PAGE in 
7.5% gels [ll]. 
Other experiments were made with plasma mem- 
branes instead of intact cells. Epididymal cells 
were isolated and the cells were preincubated for 
3 h in the absence of hormones to make them non- 
refractory to the anti-lipolytic action of hGH. 
Plasma membranes were prepared as described 
above and suspended in 20 mM Hepes, pH 7.4, 
3 mM MnCl2 and 0.1% BSA. Portions containing 
270 pg of membrane protein were taken in plastic 
tubes and put on ice. Buffer (control) or hGH solu- 
tion (700 nM) was added to a final volume of 
375 ,ul. After 10 min, 125 ,ul of 60 pM ATP con- 
taining lo8 dpm [Y-~~P]ATP was added to each 
tube. After another 10 min, 0.5 ml of 1 mM 
Na3V04, 0.01 M Na2P207, 100 mM NaF, 2 mM 
EDTA and 2 mM PMSF was added. The plasma 
membrane suspensions were pelleted by cen- 
trifugation and washed once with this buffer. The 
46 kDa phosphoprotein (see below) was then 
isolated as described above. 
After SDS-PAGE and staining with Coomassie 
blue G-250 the gels were either dried and 
autoradiographed or the protein in a gel slice cor- 
responding to the 46 kDa phosphoprotein (see 
below) band electroeluted (ISCO model 1750 elec- 
trophoretic sample concentrator) and subjected to 
phosphoamino acid analysis [ 121. BSA was used as 
standard for protein determination [131. 
3. RESULTS AND DISCUSSION 
The addition of hGH to the adipocytes caused 
rapid inhibition of the maximally noradrenaline- 
stimulated lipolysis (fig.1) (cf. [3]). In four ex- 
periments with separate cell batches hGH was add- 
ed 8-11 min after noradrenaline, when the rate of 
lipolysis was approximately maximal. The 
adipocytes were harvested after another 10 min at 
the time point of maximal hGH effect (fig.1). 
In each of the experiments 5% of the total 
adipocyte plasma membrane proteins bound to 
and could be eluted from the hGH-Sepharose with 
the 3 M KI-buffer (fig.2a). The most prominent of 
the adsorbed proteins with an M, = 75 000 enriched 
on the hGH-Sepharose column did not incorporate 
any measurable 32P (fig.2b). However, one of the 
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Fig. 1. Recorder tracings obtained simultaneously from 
two pH-stat titrators. One titrator (a) contained a cell 
suspension towhich was added noradrenaline (NA) and 
then hGH. The suspension in the other titrator (b) only 
received noradrenaline. The arrows indicate the time of 
addition of noradrenaline and hGH, respectively. 
minor proteins (constituting <5% of the proteins 
adsorbed to hGH-Sepharose according to scanning 
densitometry), with an A4, = 46000, was found to 
be markedly phosphorylated in both control and 
hGH-treated cells (fig.2b). The extent of 
phosphorylation of this protein was selectively in- 
creased in cells incubated with hGH and in four ex- 
periments with different cell batches it exceeded 
that of the control cells by 32 + 5% (mean + SE, 
p < 0.02 with Student’s t-test). Weak phosphoryla- 
tion was also noticed in some of the other proteins 
which bound to the hGH-Sepharose but no 
reproducible effect of hGH on the extent of 
phosphorylation could be detected, nor was there 
any reproducible effect on those phosphorylated 
plasma membrane proteins which did not bind to 
the hGH-Sepharose (not shown). No ‘*P- 
phosphorylated 46 kDa protein species could be 
detected in the Golgi-enriched low density 
microsomal or the cytosolic fractions. This makes 
it unlikely that the presence of the 46 kDa 
phosphoprotein in the plasma membrane fraction 
was due to contamination with these subcellular 
fractions. 
In preliminary experiments, phosphoamino acid 
analysis of the 46 kDa phosphoprotein revealed 
mostly phosphoserine. There were also indications 
of some tyrosine phosphorylation but insufficient 
to allow quantitation. In order to examine this fur- 
ther we turned to studies with isolated plasma 
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Fig.2. (a) The stained electropherograms of adipocyte 
plasma membranes (left) and the 3 M KI eluate from the 
hGH-Sepharose chromatography of solubilised adipo- 
cyte plasma membranes (right). (b) The autoradiograms 
after electrophoresis of the 3 M KI eluates from the 
hGH-Sepharose chromatography of the plasma mem- 
brane fractions from adipocytes incubated with hGH 
(+ hGH) and from control adipocytes (- hGH). The 
autoradiograms were obtained with Kodak X-Omat RP 
film using Du Pont Cronex Lightning Plus Intensifying 
screen at -80°C for 1 week. The autoradiograms and 
the corresponding electropherograms were scanned with 
a Joyce Loebl Integrating Chromoscan 3 densitometer 
and the integrals from the former were corrected for 
differences in the contents of total protein in each lane 
using the total integral of stained protein bands of that 
lane. The molecular masses correspond to the location 
of the included protein standards (Sigma MW-SDS-200). 
membranes incubated in vitro with [y-32P]ATP 
(cf. [14,15]). Also in the plasma membranes, the 
46 kDa protein was phosphorylated but no 
measurable effect of hGH was found in spite of 
variations in the incubation conditions (not 
shown). In this case the phosphoamino acids could 
be analysed quantitatively and 14% of the 32P (as 
estimated from scanning densitometry) was found 
on tyrosine (with and without hGH), with the re- 
mainder on serine and threonine (fig.3). It is possi- 
ble that a cytosolic factor is required for 
hGH-dependent phosphorylation to occur. 
The magnitude of the effect of hGH on the 
phosphorylation of the 46 kDa protein may be an 
271 
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Fig.3. Phosphoamino acid composition of the 46 kDa 
protein band (see text) excised from the polyacrylamide 
gel after SDS-PAGE. The diagram represents the 
autoradiography after the electrophoretic separation of 
the acid hydrolysate of the 46 kDa band. 
Phosphoserine, -tyrosine and -threonine (P-Ser, P-Tyr 
and P-Thr, respectively) were added as carriers before 
electrophoresis and identified in the electropherogram 
after ninhydrin staining. 
underestimate because of protein phosphatase 
catalysed dephosphorylation during the isolation 
procedure in spite of the use of phosphatase in- 
hibitors. We have noticed that the phosphorylation 
of ATP citrate-Iyase was increased three-fold by 
hGH-stimulation of adipocytes under the same ex- 
perimental conditions when measured by direct 
fractionation of the total adipocyte proteins by 
SDS-PAGE (not shown). When determined in the 
cytosolic fraction, prepared as described above, 
only a 50% increase was found. 
As to the identity of the 46 kDa phosphoprotein 
reported in this paper we can only speculate 
whether it has any relation to the hGH receptor. 
We have not been able to obtain reliable values of 
specific hormone binding to adipocyte plasma 
membrane protein due to the high background of 
non-specific binding after detergent solubilisation 
of the plasma membranes. Recently, it was shown 
that the hGH-binding receptor subunit which can 
be cross-linked to hGH in IM-9 lymphocytes does 
not become phosphorylated upon hGH-binding 
[ 161. The corresponding cross-linked receptor- 
hormone complex of the rat adipocyte has an A4, = 
134000 [17]. Naturally, it is tempting to speculate 
that, in analogy with the insulin receptor structure, 
this corresponds to a hormone binding c~ subunit 
and that the 46 kDa protein represents an 
autophosphorylated p subunit. A native receptor 
containing two of each such subunits would fit 
with the reported molecular mass of 300 kDa for 
the rabbit liver growth hormone receptor [18]. 
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